Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dávid Lukáč
Observed name:
David Lukac
Institutions:
University of Southern Denmark,
University Hospital Olomouc,
Institute of Molecular and Translational Medicine,
Palacký University Olomouc
Observed institutions:
University of Southern Denmark,
University Hospital Olomouc,
Institute of Molecular and Translational Medicine,
Palacký University Olomouc
ORCID:
0000-0003-0219-1448
Observed ORCID:
0000-0003-0219-1448
OpenAlex ID:
A5103256612
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
2023
·
Tereza Buchtova
, David Lukac
, et al.
·
International Journal of Molecular Sciences
·
38
PDF
DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps
2024
·
Zuzana Machacova
, Katarina Chroma
, et al.
·
Nature Communications
·
31
PDF
Emetine blocks DNA replication via proteosynthesis inhibition not by targeting Okazaki fragments
2022
·
David Lukac
, Zuzana Machacova
, et al.
·
Life Science Alliance
·
14
PDF
Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET
2021
·
Tereza Buchtova
, Zdenek Skrott
, et al.
·
Molecular Oncology
·
14
PDF
The need for speed: drivers and consequences of accelerated replication forks
2025
·
Dávid Lukáč
, Katarína Chromá
, et al.
·
Communications Biology
·
4
PDF
Author response for "Cannabidiol‐induced activation of the metallothionein pathway impedes anti‐cancer effects of disulfiram and its metabolite CuET"
2021
·
Tereza Buchtova
, Zdenek Skrott
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
6
Citation count:
101
H-index:
4
I10-index:
4
Year
Topic
Type